세계의 티로신 키나아제 저해제 전망

Highlights:

This report provides a detailed understanding of the current market scenario for tyrosine kinase inhibitors and an assessment of the market’s growth over the period from 2023 through the end of 2028. The report highlights major trends and challenges that affect the global market and the vendor landscape.

Report Scope:

In this report, the market has been segmented based on type, application and geography. The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. Using 2022 as the base year, the report provides estimated market data for the forecast period of 2023 through 2028. Market values have been estimated based on the total revenue of tyrosine kinase inhibitor product providers.

The report covers the market for tyrosine kinase inhibitors with regard to the user base across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for tyrosine kinase inhibitors in 2022 and provides projections for the expected market size through 2028. The scope of the study includes tyrosine kinase inhibitor drugs that are already available in the market as well as future prospects.

Report Includes:

• An overview of the global market for tyrosine kinase inhibitors
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Definition of tyrosine kinase inhibitors and their characteristics, and coverage of the market's dynamics, specifically drivers, inhibitors and opportunities
• Discussions of novel tyrosine kinase inhibitors and their utility in the human trials
• Examination of the technologies and methods used for the creation of novel targets and their therapeutic approaches
• Discussions of market challenges and how to overcome them if the market is to reach its commercialization potential, pipeline drugs and relevant patents
• Information on recent mergers and acquisitions, collaborations, partnerships and product introductions
• Profiles of major players in the market

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview

• Kinase Inhibitors
• Types of Kinase Inhibitors
• Tyrosine Kinase Inhibitors
• Regulatory Scenario
• Market Dynamics
• Drivers
• Restraints
• Opportunities

Chapter 4 Market Breakdown by Type and Application

• Market for Tyrosine Kinase Inhibitors, by Type
• Receptor Tyrosine Kinase Inhibitors
• Non-receptor Tyrosine Kinase Inhibitors
• Market for Tyrosine Kinase Inhibitors, by Application
• Lung Cancer
• Chronic Myelogenous Leukemia (CML)
• Others

Chapter 5 Market Breakdown by Region

• Global Market for Tyrosine Kinase Inhibitors, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 ESG Development

• Introduction to ESG
• The Sustainability of Tyrosine Kinase Inhibitor Manufacturers in the Industry
• Pharma End User Sustainability in the Industry
• Case Study
• BCC Research Viewpoint

Chapter 7 Industry Structure

• Ranking of Top Companies
• Pipeline Analysis
• Patent Analysis
• Emerging Trends

Chapter 8 Company Profiles

• ASTRAZENECA
• BAYER AG
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• BRISTOL-MYERS SQUIBB CO.
• EISAI CO. LTD.
• F. HOFFMANN-LA ROCHE LTD.
• JOHNSON & JOHNSON SERVICES INC.
• NOVARTIS AG
• PFIZER INC.